New Workforce report reveals pharmacists lead ARRS hiring in PCNs

Latest figures highlight the increasing role of pharmacists in Primary Care Networks

A recent NHS England report on Primary Care Network Workforce reveals that pharmacists are the most frequently hired role under the Additional Roles Reimbursement Scheme (ARRS).

These figures indicate a growing reliance on pharmacists to provide essential care and support within PCNs, reflecting their critical role in modern healthcare delivery.

As of April 2024, there were 5,308 full-time equivalent (FTE) pharmacists working in PCNs, an increase from 5,163 in January 2024.

This growth underscores the integral role pharmacists play in the healthcare system, particularly within the framework of PCNs.

Pharmacists contribute significantly to direct patient care by managing medications, offering clinical advice, and supporting the broader healthcare team.

PCNs were established in July 2019 to enhance the accessibility and integration of primary, mental health, and community care.

The workforce within PCNs predominantly consists of direct patient care staff, funded by the ARRS, which grants PCNs the flexibility to recruit roles that best meet the needs of their local populations.

Initially, recruitment focused on clinical pharmacists and social prescribing link workers, but it has since expanded to include a variety of roles.

In addition to pharmacists, other prominent roles in PCNs include care coordinators and social prescribing link workers.

In April 2024, there were 4,771 FTE care coordinators, up from 4,626 in January, and 2,845 FTE social prescribing link workers, slightly down from 2,866 in January.

Overall, there are over 24,000 FTE ARRS roles working in PCNs across England, highlighting the scheme's expansive impact on the primary care workforce.

Ahead of the general elections, the Conservative party has pledged to expand the Pharmacy First initiative to free up 20 million GP appointments if they win the general election on 4 July.

They also promise to build 100 new GP surgeries and modernise a further 150, backed by £1 billion in annual funding by 2029/30.

This funding would come from reducing the number of NHS managers and halving the spend on consultants in the public sector.

Despite these promising developments for the pharmacists, challenges remain.

Earlier this year, a study emphasised the need to address issues within the ARRS, including funding, estates, and oversight, to realise its full potential.

Addressing these challenges is crucial for ensuring that the expanded roles within PCNs can effectively meet the healthcare needs of their communities.